P2X7受体过度激活是COVID-19神经病理的元凶
本文探讨SARS-CoV-2感染通过细胞因子风暴和ATP介导的P2X7受体过度激活,引发NLRP3炎症小体刺激和神经炎症,导致神经损伤,并认为P2X7受体拮抗可能是防治COVID-19神经系统并发症的策略。
要点
- SARS-CoV-2感染可触发细胞因子风暴,促炎因子和病毒可能穿过血脑屏障进入中枢神经系统。
- 感染诱导的细胞外ATP升高可能过度激活P2X7受体,进而刺激NLRP3炎症小体,介导神经侵袭和神经炎症。
- P2X7受体拮抗可能是预防或治疗COVID-19患者神经系统并发症的有前景策略。
核心结论
- SARS-CoV-2感染可能通过P2X7受体过度激活和NLRP3炎症小体刺激介导神经炎症,P2X7受体拮抗是潜在防治策略。
主要发现
- COVID-19并发症与针对SARS-CoV-2入侵的免疫炎症反应加剧有关,促炎因子大量释放入血形成细胞因子风暴。
- 促炎因子和病毒均可穿过血脑屏障进入中枢神经系统,激活神经炎症反应并伴出血性病变和神经元损伤。
- SARS-CoV-2感染诱导的细胞外ATP升高可能触发P2X7受体过度激活,导致NLRP3炎症小体刺激作为神经侵袭和神经炎症过程的关键介质。
- 伴有神经免疫激活的中枢神经系统疾病患者(如抑郁症、帕金森病和阿尔茨海默病)可能对SARS-CoV-2感染易感性增加或出现严重状况。
临床怎么用
- 对COVID-19患者应关注神经系统症状,并考虑神经炎症机制在其中的作用。
- 伴有神经免疫激活的中枢神经系统疾病患者(如抑郁症、帕金森病、阿尔茨海默病)可能需加强防护和监测。
- P2X7受体拮抗可能作为预防或治疗COVID-19神经系统并发症的潜在策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Scientists and health professionals are exhaustively trying to contain the coronavirus disease 2019 (COVID-19) pandemic by elucidating viral invasion mechanisms, possible drugs to prevent viral infection/replication, and health cares to minimize individual exposure. Although neurological symptoms are being reported worldwide, neural acute and long-term consequences of SARS-CoV-2 are still unknown. COVID-19 complications are associated with exacerbated immunoinflammatory responses to SARS-CoV-2 invasion. In this scenario, pro-inflammatory factors are intensely released into the bloodstream, causing the so-called "cytokine storm". Both pro-inflammatory factors and viruses may cross the blood-brain barrier and enter the central nervous system, activating neuroinflammatory responses accompanied by hemorrhagic lesions and neuronal impairment, which are largely described processes in psychiatric disorders and neurodegenerative diseases. Therefore, SARS-CoV-2 infection could trigger and/or worse brain diseases. Moreover, patients with central nervous system disorders associated to neuroimmune activation (e.g. depression, Parkinson's and Alzheimer's disease) may present increased susceptibility to SARS-CoV-2 infection and/or achieve severe conditions. Elevated levels of extracellular ATP induced by SARS-CoV-2 infection may trigger hyperactivation of P2X7 receptors leading to NLRP3 inflammasome stimulation as a key mediator of neuroinvasion and consequent neuroinflammatory processes, as observed in psychiatric disorders and neurodegenerative diseases. In this context, P2X7 receptor antagonism could be a promising strategy to prevent or treat neurological complications in COVID-19 patients.
引用
- Ribeiro DE, Oliveira-Giacomelli Á, Glaser T, et al. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol Psychiatry. 2020. PMID: 33328588. doi:10.1038/s41380-020-00965-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。